식물 유래 원료의약품(API) 시장 보고서(2025년)

Plant-based active pharmaceutical ingredients (APIs) are biologically active compounds derived from plants and are essential in the formulation of medications. These ingredients are important for their therapeutic effects, which can include treating, preventing, or managing various health conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types of plant-based active pharmaceutical ingredients (APIs) include alkaloids, glycosides, cannabinoids, flavonoids, terpenes and terpenoids, polyphenols, saponins, and others. Alkaloids are a diverse group of naturally occurring organic compounds, most of which contain basic nitrogen atoms. Plant-based active pharmaceutical ingredients (APIs) are sourced from various plant parts, including leaves, roots, bark, flowers, seeds, fruits, resins, gums, and other natural sources. These ingredients are distributed through various channels, such as online retailers, supermarkets and hypermarkets, specialty food stores, and foodservice providers, and are widely used across industries such as pharmaceuticals, nutraceuticals, herbal-based industries, and others.

The plant-based active pharmaceutical ingredients (API) market research report is one of a series of new reports from The Business Research Company that provides plant-based active pharmaceutical ingredients (API) market statistics, including plant-based active pharmaceutical ingredients (API) industry global market size, regional shares, competitors with a plant-based active pharmaceutical ingredients (API) market share, detailed plant-based active pharmaceutical ingredients (API) market segments, market trends and opportunities, and any further data you may need to thrive in the plant-based active pharmaceutical ingredients (API) industry. This plant-based active pharmaceutical ingredients (API) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based active pharmaceutical ingredients (API) market size has grown strongly in recent years. It will grow from$30.22 billion in 2024 to $32.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to factors such as the increasing use of traditional herbal medicine practices, a growing demand for natural remedies, the rise of early pharmaceutical formulations, the expanding global trade of medicinal herbs, and the increasing industrialization of botanical drugs.

The plant-based active pharmaceutical ingredients (API) market size is expected to see strong growth in the next few years. It will grow to$42.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to factors such as rising consumer preference for natural medicines, increasing investment in plant-based drug research, expanding applications in the treatment of chronic diseases, and growing collaborations between the pharmaceutical and botanical industries. Key trends during this period include AI-driven drug discovery, advanced plant tissue culture techniques, precision fermentation for plant-derived compounds, and green extraction methods aimed at sustainable production.

The rising consumer demand for natural and organic products is expected to drive the growth of the plant-based active pharmaceutical ingredients (API) market. Natural and organic products are those made from ingredients that are naturally sourced, minimally processed, and free from synthetic chemicals and genetically modified organisms (GMOs). This shift towards natural and organic products is largely due to increased health awareness and concerns over synthetic chemicals, with consumers becoming more conscious of the potential risks associated with synthetic ingredients. Plant-based active pharmaceutical ingredients (APIs) cater to this demand by providing effective, chemical-free medicinal benefits that align with the consumer preference for clean, safe, and sustainable healthcare options. For example, in May 2024, LETIS S.A., an Argentina-based organic certification authority, reported that organic food sales reached $61.67 billion in 2022, marking a 4.3% increase from the previous period. Additionally, other organic products contributed $5.906 billion, reflecting a 1.6% growth. As a result, the growing preference for natural and organic products is fueling the expansion of the plant-based active pharmaceutical ingredients (API) market.

Leading companies in the plant-based active pharmaceutical ingredients (API) market are focusing on developing innovative solutions such as plant-based squalene, which offer sustainable and ethical alternatives to traditional animal-derived sources. Plant-based squalene, derived from plants such as amaranth, olives, and sugarcane, serves as an ethical substitute for shark-derived squalene in pharmaceuticals, cosmetics, and vaccines. For instance, in October 2023, Evonik Industries AG, a Germany-based specialty chemicals company, launched PhytoSquene, the first GMP-quality, plant-based squalene sourced from amaranth oil. This innovation provides a sustainable alternative to shark-derived squalene, ensuring high purity, consistent batch quality, and compliance with European Pharmacopoeia (Ph. Eur.) standards. Squalene is an important ingredient in vaccine adjuvants, as it enhances the immune response. By offering a plant-based version, PhytoSquene addresses concerns about biodiversity, reduces reliance on animal-derived sources, and respects cultural and religious preferences.

In March 2024, Roquette Freres, a France-based provider of pharmaceutical excipients, acquired IFF Pharma Solutions for an undisclosed sum. This acquisition aims to strengthen Roquette's position in the pharmaceutical excipients market by broadening its product portfolio and expertise in drug delivery. This move is expected to accelerate Roquette's growth in the health and nutrition sectors, positioning the company as a key partner for pharmaceutical companies. IFF Pharma Solutions, a US-based pharmaceutical company, specializes in offering plant-based active pharmaceutical ingredients.

Major players in the plant-based active pharmaceutical ingredients (API) market are Evonik Industries AG, Roquette Freres, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Koninklijke DSM NV, Alembic Pharmaceuticals Ltd, Seppic, Indena SpA, PAI Pharma, Centroflora Group, Alkaloids Corporation, SCL Lifesciences Ltd, Alchem International Pvt Ltd, AMGIS Lifescience Ltd, C2 Pharma, PhytoHealth Corp, Bright Green Corporation, Sichuan Xieli Pharmaceutical Co Ltd, Brains Bioceutical Corp, Organotechnie, and HimPharm.

North America was the largest region in the plant-based active pharmaceutical ingredients (API) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in plant-based active pharmaceutical ingredients (API) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the plant-based active pharmaceutical ingredients (API) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based active pharmaceutical ingredients (API) market consists of sales of botanical extracts, plant-based steroids, essential oils, flavonoids, and botanical extracts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Active Pharmaceutical Ingredients (API) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based active pharmaceutical ingredients (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based active pharmaceutical ingredients (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based active pharmaceutical ingredients (api) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Alkaloids; Glycosides; Cannabinoids; Flavonoid; Terpenes And Terpenoids; Polyphenols; Saponins; Other Product Types
• 2) By Source: Leaves; Roots; Bark; Flowers; Seeds; Fruits; Resin And Gums; Other Sources
• 3) By Distribution Channel: Online Retailers; Supermarkets Or Hypermarkets; Specialty Food Stores; Foodservice
• 4) By End-Use: Pharmaceuticals; Nutraceuticals; Herbal Based Industries; Other End-Uses
• Subsegments:
• 1) Alkaloids: Morphine Alkaloids; Tropane Alkaloids; Quinolizidine Alkaloids; Indole Alkaloids; Isoquinoline Alkaloids; Pyrrolizidine Alkaloids
• 2) By Glycosides: Cardiac Glycosides; Anthraquinone Glycosides; Flavonoid Glycosides; Saponin Glycosides; Cyanogenic Glycosides
• 3) Cannabinoids: Tetrahydrocannabinol (THC); Cannabidiol (CBD); Cannabigerol (CBG); Cannabichromene (CBC); Cannabinol (CBN)
• 4) Flavonoid: Flavones; Flavonols; Isoflavones; Flavanones; Anthocyanins
• 5) Terpenes And Terpenoids: Monoterpenes; Sesquiterpenes; Diterpenes; Triterpenes; Tetraterpenes
• 6) Polyphenols: Phenolic Acids; Stilbenes; Lignans; Flavonoid Polyphenols
• 7) Saponins: Steroidal Saponins; Triterpenoid Saponins
• 8) Other Product Types: Coumarins; Tannins; Lignins; Phenolic Glycosides
• Companies Mentioned: Evonik Industries AG; Roquette Freres; Sun Pharmaceutical Industries Ltd; Aurobindo Pharma; Koninklijke DSM NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plant-Based Active Pharmaceutical Ingredients (API) Market Characteristics

3. Plant-Based Active Pharmaceutical Ingredients (API) Market Trends And Strategies

4. Plant-Based Active Pharmaceutical Ingredients (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Plant-Based Active Pharmaceutical Ingredients (API) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plant-Based Active Pharmaceutical Ingredients (API) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Growth Rate Analysis
• 5.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Total Addressable Market (TAM)

6. Plant-Based Active Pharmaceutical Ingredients (API) Market Segmentation

• 6.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkaloids
• Glycosides
• Cannabinoids
• Flavonoid
• Terpenes And Terpenoids
• Polyphenols
• Saponins
• Other Product Types
• 6.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leaves
• Roots
• Bark
• Flowers
• Seeds
• Fruits
• Resin And Gums
• Other Sources
• 6.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Retailers
• Supermarkets Or Hypermarkets
• Specialty Food Stores
• Foodservice
• 6.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals
• Nutraceuticals
• Herbal Based Industries
• Other End-Uses
• 6.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Alkaloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine Alkaloids
• Tropane Alkaloids
• Quinolizidine Alkaloids
• Indole Alkaloids
• Isoquinoline Alkaloids
• Pyrrolizidine Alkaloids
• 6.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Glycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Glycosides
• Anthraquinone Glycosides
• Flavonoid Glycosides
• Saponin Glycosides
• Cyanogenic Glycosides
• 6.7. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)
• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Cannabinol (CBN)
• 6.8. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Flavonoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flavones
• Flavonols
• Isoflavones
• Flavanones
• Anthocyanins
• 6.9. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Terpenes And Terpenoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoterpenes
• Sesquiterpenes
• Diterpenes
• Triterpenes
• Tetraterpenes
• 6.10. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Polyphenols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenolic Acids
• Stilbenes
• Lignans
• Flavonoid Polyphenols
• 6.11. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Saponins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroidal Saponins
• Triterpenoid Saponins
• 6.12. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coumarins
• Tannins
• Lignins
• Phenolic Glycosides

7. Plant-Based Active Pharmaceutical Ingredients (API) Market Regional And Country Analysis

• 7.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market

• 8.1. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plant-Based Active Pharmaceutical Ingredients (API) Market

• 9.1. China Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 9.2. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plant-Based Active Pharmaceutical Ingredients (API) Market

• 10.1. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market

• 11.1. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 11.2. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 12.1. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 13.1. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market

• 14.1. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 14.2. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 15.1. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 15.2. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plant-Based Active Pharmaceutical Ingredients (API) Market

• 16.1. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market

• 17.1. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plant-Based Active Pharmaceutical Ingredients (API) Market

• 18.1. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market

• 19.1. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market

• 20.1. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 21.1. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 21.2. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 22.1. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 23.1. North America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 23.2. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plant-Based Active Pharmaceutical Ingredients (API) Market

• 24.1. USA Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 24.2. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market

• 25.1. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 25.2. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 26.1. South America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 26.2. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market

• 27.1. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market

• 28.1. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 28.2. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market

• 29.1. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 29.2. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape And Company Profiles

• 30.1. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape
• 30.2. Plant-Based Active Pharmaceutical Ingredients (API) Market Company Profiles
  • 30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roquette Freres Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis

31. Plant-Based Active Pharmaceutical Ingredients (API) Market Other Major And Innovative Companies

• 31.1. Alembic Pharmaceuticals Ltd
• 31.2. Seppic
• 31.3. Indena SpA
• 31.4. PAI Pharma
• 31.5. Centroflora Group
• 31.6. Alkaloids Corporation
• 31.7. SCL Lifesciences Ltd
• 31.8. Alchem International Pvt Ltd
• 31.9. AMGIS Lifescience Ltd
• 31.10. C2 Pharma
• 31.11. PhytoHealth Corp
• 31.12. Bright Green Corporation
• 31.13. Sichuan Xieli Pharmaceutical Co Ltd
• 31.14. Brains Bioceutical Corp
• 31.15. Organotechnie

32. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plant-Based Active Pharmaceutical Ingredients (API) Market

34. Recent Developments In The Plant-Based Active Pharmaceutical Ingredients (API) Market

35. Plant-Based Active Pharmaceutical Ingredients (API) Market High Potential Countries, Segments and Strategies

• 35.1 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34929_Plant_Based_Active_Pharmaceutical_Ingredients_API_GMR_2025